Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1038 | 1051 | 1048 | 955 | 1144 | 1695 |
Fund Return | 3.76% | 5.1% | 4.83% | -1.51% | 2.72% | 5.42% |
Place in category | 224 | 196 | 236 | 290 | 203 | 102 |
% in Category | 56 | 50 | 64 | 77 | 66 | 41 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Marlborough Special Situations A Ac | 672.8M | 4.42 | -10.18 | 5.48 | ||
Marlborough Special Situations Fund | 672.8M | 4.68 | -9.50 | 6.23 | ||
Marlborough UK MicroCap Grow P Acc | 624.14M | 5.41 | -11.58 | 6.14 | ||
Multi-Cap Fund Class A Income | 270.33M | 3.57 | 0.62 | 11.48 | ||
Multi-Cap Fund Class P Income | 270.33M | 3.83 | 1.38 | 12.33 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Liontrust Special Situations Fund R | 40.78M | -1.48 | 2.55 | 6.09 | ||
Liontrust Special Situations Fund A | 6.01M | 0.92 | 2.88 | 7.38 | ||
Liontrust Special Situations Fund I | 2.85B | 1.61 | 1.63 | 7.61 | ||
Fidelity Special Situations Fund W | 2.38B | 4.72 | 7.67 | 6.67 | ||
Fidelity Special Situations | 442.47M | -1.00 | 7.74 | 4.82 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Shell | GB00BP6MXD84 | 5.05 | 32.90 | -0.66% | |
AstraZeneca | GB0009895292 | 4.70 | 12,110.0 | -0.46% | |
HSBC | GB0005405286 | 4.28 | 697.00 | +0.07% | |
BP | GB0007980591 | 3.50 | 491.30 | +0.41% | |
iShares FTSE 250 UCITS | IE00B00FV128 | 3.26 | 1,951.0 | -0.25% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | BUY | Strong Buy | Strong Buy |
Summary | Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review